Robert Powalski
Obstetrics & Gynecology · Kenmore, NYNPI 1134160872
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.2% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $830 and has fallen 97.3% since, to $22 in 2024.
Across 158 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Therapeuticsmd, Inc.$277
- AbbVie$219
- Exeltis, USA Inc.$199
- Astellas Pharma US Inc$179
- Amgen$173
- Pfizer$166
- plus $2K from 32 others
What the payments were for
- Food & beverage$2,52592%
- Education$2128%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Therapeuticsmd, Inc. | 15 | $277 |
| AbbVie(2 entities) | 12 | $219 |
| Exeltis, USA Inc. | 11 | $199 |
| Astellas Pharma US Inc | 6 | $179 |
| Amgen | 10 | $173 |
| Pfizer | 11 | $166 |
| Mayne Pharma Commercial LLC | 8 | $129 |
| AMAG Pharmaceuticals, Inc. | 12 | $126 |
| Daiichi Sankyo Inc. | 7 | $119 |
| Scynexis, Inc. | 7 | $115 |
| Merck | 6 | $80 |
| Organon | 5 | $76 |
| Hologic Sales And Service, LLC | 3 | $66 |
| Exact Sciences | 3 | $65 |
| Bayer | 4 | $63 |
| Mylan Pharmaceuticals Inc. | 3 | $61 |
| Avion Pharmaceuticals | 3 | $53 |
| Duchesnay USA Incorporated | 4 | $52 |
| Coopersurgical, Inc. | 3 | $52 |
| Evofem Biosciences, Inc. | 2 | $49 |
| Myovant Sciences Inc. | 2 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Vertical Pharmaceuticals, LLC | 3 | $42 |
| Millicent US Inc | 2 | $30 |
| GE HealthCare | 1 | $29 |
| Gilead | 1 | $24 |
| Virtus Pharmaceuticals LLC | 1 | $22 |
| Shield Therapeutics Inc | 1 | $21 |
| Agile Therapeutics, Inc. | 1 | $21 |
| Roche Diagnostics Corporation | 1 | $20 |
| Radius Health, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Biogen | 1 | $16 |
| Si-bone, Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
| Covidien LP | 1 | $11 |
How this compares
$2,737 in reported general payments places this provider in the 85th percentile of 2,673 obstetrics & gynecology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 24 | $853 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Kenmore
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.